SCHEMBL4417829

SCHEMBL4417829

Cc1ccc(NC(=O)c2cc(C#N)cc(C(C)(C)C)c2)cc1-c1cc(C(=O)NCC(C)(C)C)on1

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TEK Q02763 4/20 0.45
RAF1 P04049 16/20 0.42
BRAF P15056 16/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4412713 0.88 BRAF (0.47) RAF1BRAF
SCHEMBL4552227 0.88 RAF1 (0.44) RAF1BRAF
SCHEMBL4410934 0.88 RAF1 (0.44) RAF1BRAF
SCHEMBL5593338 0.87 RAF1 (0.44) TEKRAF1BRAF
SCHEMBL4408574 0.87 RAF1 (0.44) RAF1BRAF
SCHEMBL4411086 0.87 NR1H4 (0.46) RAF1BRAF
SCHEMBL4565782 0.86 BRAF (0.43) RAF1BRAF
SCHEMBL4410316 0.86 RAF1 (0.43) RAF1BRAF
SCHEMBL5593020 0.86 RAB9A (0.49) TEKRAF1BRAF
SCHEMBL5593016 0.86 TEK (0.53) TEKBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed